Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Transforming growth factor beta and the liver.

Bissell DM, Roulot D, George J.

Hepatology. 2001 Nov;34(5):859-67. Review. No abstract available.

PMID:
11679955
2.

[Smad 7 and post-receptor signal regulation of transforming growth factor-beta1].

Wu JX, Meng XJ, Chen YW, Cheng JL, Li DG, Lu HM.

Zhonghua Gan Zang Bing Za Zhi. 2003 May;11(5):315-7. Review. Chinese. No abstract available.

PMID:
12773256
3.

Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta.

Park YN, Chae KJ, Oh BK, Choi J, Choi KS, Park C.

Hepatogastroenterology. 2004 Mar-Apr;51(56):396-400.

PMID:
15086168
4.

Transforming growth factor beta can mediate apoptosis via the expression of TRAIL in human hepatoma cells.

Herzer K, Ganten TM, Schulze-Bergkamen H, Grosse-Wilde A, Koschny R, Krammer PH, Walczak H.

Hepatology. 2005 Jul;42(1):183-92.

PMID:
15962328
5.

Transforming growth factor -beta receptor signaling in cancer.

Narayan S, Thangasamy T, Balusu R.

Front Biosci. 2005 May 1;10:1135-45. Review.

PMID:
15769612
6.

Toward the molecular dissection of primary biliary cirrhosis.

Hirschfield GM, Siminovitch KA.

Hepatology. 2009 Nov;50(5):1347-50. doi: 10.1002/hep.23252. No abstract available.

PMID:
19876938
7.

[Signaling pathways of transforming growth factor beta family members].

Zimowska M.

Postepy Biochem. 2006;52(4):360-6. Review. Polish.

PMID:
17536504
8.

Transforming growth factor-beta signaling and cirrhosis.

Wrana JL.

Hepatology. 1999 Jun;29(6):1909-10. No abstract available.

PMID:
10347138
9.

[TGF-beta signal transduction and Smad].

Miyazono K, Kawabata M.

Seikagaku. 1997 Jun;69(6):424-8. Review. Japanese. No abstract available.

PMID:
9234646
10.

Growth factor regulation of kinases.

Heldin CH.

Ernst Schering Res Found Workshop. 2001;(34):1-18. Review. No abstract available.

PMID:
11394040
11.

TGFbeta signaling: receptors, transducers, and Mad proteins.

Massagué J.

Cell. 1996 Jun 28;85(7):947-50. Review. No abstract available.

13.

A novel method in order to evaluate the efficacies and the safeties of new drugs for hepatocellular carcinoma with loss of transforming growth factor-beta signaling.

Moriguchi H.

Hepatology. 2009 Dec;50(6):2050-1; author reply 2051. doi: 10.1002/hep.23352. No abstract available.

PMID:
19937676
14.
15.

Parenchymal transforming growth factor beta-1: its type II receptor and Smad signaling pathway correlate with inflammation and fibrosis in chronic liver disease of viral etiology.

Calabrese F, Valente M, Giacometti C, Pettenazzo E, Benvegnu L, Alberti A, Gatta A, Pontisso P.

J Gastroenterol Hepatol. 2003 Nov;18(11):1302-8.

PMID:
14535988
16.
17.

[Molecular study of the hepatic inflammation to fibrosis to cancer axis].

Cai WM.

Zhonghua Gan Zang Bing Za Zhi. 2009 Oct;17(10):799-800. Review. Chinese. No abstract available.

PMID:
19874704
18.

Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling.

Torbenson M, Marinopoulos S, Dang DT, Choti M, Ashfaq R, Maitra A, Boitnott J, Wilentz RE.

Hum Pathol. 2002 Sep;33(9):871-6.

PMID:
12378510
19.

Transforming growth factor-beta signalling in brain disorders.

Vivien D, Ali C.

Cytokine Growth Factor Rev. 2006 Feb-Apr;17(1-2):121-8. Epub 2005 Nov 3. Review.

PMID:
16271500
20.

[Receptors and signal transduction for the TGF-beta related factors].

Miyazono K.

Nihon Ronen Igakkai Zasshi. 1999 Mar;36(3):162-6. Review. Japanese. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk